Production of recombinant proteins is a steadily growing industry in Russia and all over the world. Both producer and substance should be properly characterized and tested against all safety criteria. One of the mandatory requirements to the mentioned drugs is the assessment of the content of residual DNA-producing cells. which should be less than 10 ng per dose. https://www.lightemupsequences.com/mega-pick-Danger-Area-Under-Construction-Do-Not-Enter-mega-offer/